Renibus Therapeutics

United States
Loretto, Tennessee, United States, 76092

Company profile

Renibus Therapeutics company profile

Renibus Therapeutics is a clinical-stage biotech company transforming outcomes in cardiothoracic surgical patients. It has developed a portfolio of products that activate multiple cytoprotective pathways, including organ protection via preconditioning.

Business identity

Contact email
[email protected]
Phone number
682 285 1711
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2016-01-01, Year

Headquarters

Postal code
76092
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
8
Total equity funding
$181.7M
Last funding
Series B / $25M / 2023-09-12
Last equity funding
Series B / $25M
Investors
1
Lead investors
1
Founders
2
Articles
42

Founders and investors

Founders

Alvaro GuillemD. Jeffrey Keyser

Lead investors

Oxford Finance LLC

Investors

Oxford Finance LLC